期刊文献+

Association of the Cellular Apoptosis Susceptibility Protein with HBV Infection in Hepatocellular Carcinoma

Association of the Cellular Apoptosis Susceptibility Protein with HBV Infection in Hepatocellular Carcinoma
下载PDF
导出
摘要 Objective The cellular apoptosis susceptibility(CAS) protein plays a regulatory role in the induction of cell death in tumor cells. The objective of this study was to investigate the association of the expression of CAS protein with HBV infection in the development of HCC. Methods The expression level of CAS was measured with immunohistochemistry. The occurrence of HBs Ag, HBe Ag and HBV DNA in HCC were concurrently examined with immunohistochemistry and in situ hybridization, respectively. Results The results showed that the CAS protein was detected in 86%(43/50), 70%(7/10), 15%(3/20) and none(0/20) of livers from patients with HCC, cholangiocarcinoma, cirrhosis and hepatitis, respectively. Furthermore, the level of CAS protein was higher in poorly differentiated tumors than moderately or well differentiated HCC. Interestingly, the CAS was stained significantly stronger in HBV-infected HCC than in non-HBV infected tissues(P < 0.01). Conclusions The expression of CAS is facilitated by HBV infection in HCC, suggesting that CAS might be a prognostic marker and a putative therapeutic target for HCC. Objective The cellular apoptosis susceptibility(CAS) protein plays a regulatory role in the induction of cell death in tumor cells. The objective of this study was to investigate the association of the expression of CAS protein with HBV infection in the development of HCC. Methods The expression level of CAS was measured with immunohistochemistry. The occurrence of HBs Ag, HBe Ag and HBV DNA in HCC were concurrently examined with immunohistochemistry and in situ hybridization, respectively. Results The results showed that the CAS protein was detected in 86%(43/50), 70%(7/10), 15%(3/20) and none(0/20) of livers from patients with HCC, cholangiocarcinoma, cirrhosis and hepatitis, respectively. Furthermore, the level of CAS protein was higher in poorly differentiated tumors than moderately or well differentiated HCC. Interestingly, the CAS was stained significantly stronger in HBV-infected HCC than in non-HBV infected tissues(P < 0.01). Conclusions The expression of CAS is facilitated by HBV infection in HCC, suggesting that CAS might be a prognostic marker and a putative therapeutic target for HCC.
机构地区 [
出处 《国际感染病学(电子版)》 CAS 2014年第2期77-81,共5页 Infection International(Electronic Edition)
关键词 Cellular apoptosis susceptibility protein Hepatocellular carcinoma Hepatitis B virus Cellular apoptosis susceptibility protein Hepatocellular carcinoma Hepatitis B virus
  • 相关文献

参考文献4

二级参考文献66

  • 1陈国凤,王琳,成军,张健,刘妍,刘敏,张玲霞,李莉.基因表达谱芯片技术筛选HBV DNA多聚酶RNase H反式调节基因[J].中西医结合肝病杂志,2005,15(2):81-84. 被引量:2
  • 2姜兆金,雷明君.拉米夫定治疗乙型肝炎后活动性肝硬化的临床应用[J].传染病信息,2007,20(1):54-55. 被引量:4
  • 3马兴璇.血清HBV-DNA含量及乙型肝炎标志物模式与肝炎后肝硬化的关系[J].检验医学与临床,2007,4(3):212-213. 被引量:3
  • 4[1]Parkin DM,Bray F,Ferlay J,Pisani P.Global cancer statistics,2002.CA Cancer } Clin 2005; 55:74-108
  • 5[2]Eggel H.Ueber das primare Carcinom der Leber.Beitr Pathol Anat 1910; 30:506-604
  • 6[3]McGlynn KA,London WT.Epidemiology and natural history of hepatocellular carcinoma.Best Pract Res Clin Gastroenterol 2005; 19:3-23
  • 7[4]Chu CM.Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.J Gastroenterol Hepatol 2000; 15 Suppl:E25-E30
  • 8[5]Yu MW,Yeh SH,Chen PJ,Liaw YF,Lin CL,Liu CJ,Shih WL,Kao JH,Chen IDS,Chen CJ.Hepatitis B virus genotype and DNA level and hepatocellular carcinoma:a prospective study in men.J Natl Cancer Inst 2005; 97:265-272
  • 9[6]Liu CJ,Chen BF,Chen PJ,Lai MY,Huang WL,Kao JH,Chen DS.Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.J Infect Dis 2006; 193:1258-1265
  • 10[7]Marchio A,Pineau P,Meddeb M,Terris B,Tiollais P,Bernheim A,Dejean A.Distinct chromosomal abnormality pattern in primary liver cancer of non-B,non-C patients.Oncogene 2000; 19:3733-3738

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部